Works matching AU Minato, Koichi


Results: 85
    1
    2
    3
    4
    5

    Multicenter study of zoledronic acid administration in non-small-cell lung cancer patients with bone metastasis: Thoracic Oncology Research Group (TORG) 1017.

    Published in:
    Molecular & Clinical Oncology, 2019, v. 11, n. 4, p. 349, doi. 10.3892/mco.2019.1903
    By:
    • Nakahara, Yoshiro;
    • Hosomi, Yukio;
    • Shibuya, Masahiko;
    • Mitsufuji, Hisashi;
    • Katagiri, Masato;
    • Naoki, Katsuhiko;
    • Soejima, Kenzo;
    • Nogami, Naoyuki;
    • Nagase, Seisuke;
    • Nishikawa, Masanori;
    • Minato, Koichi;
    • Takiguchi, Yuichi;
    • Seki, Nobuhiko;
    • Yamada, Kouzo;
    • Seto, Takashi;
    • Okamoto, Hiroaki
    Publication type:
    Article
    6
    7

    Five-year follow-up results from phase II studies of nivolumab in Japanese patients with previously treated advanced non-small cell lung cancer: pooled analysis of the ONO-4538-05 and ONO-4538-06 studies.

    Published in:
    Japanese Journal of Clinical Oncology, 2021, v. 51, n. 1, p. 106, doi. 10.1093/jjco/hyaa157
    By:
    • Saka, Hideo;
    • Nishio, Makoto;
    • Hida, Toyoaki;
    • Nakagawa, Kazuhiko;
    • Sakai, Hiroshi;
    • Nogami, Naoyuki;
    • Atagi, Shinji;
    • Takahashi, Toshiaki;
    • Horinouchi, Hidehito;
    • Takenoyama, Mitsuhiro;
    • Katakami, Nobuyuki;
    • Tanaka, Hiroshi;
    • Takeda, Koji;
    • Satouchi, Miyako;
    • Isobe, Hiroshi;
    • Maemondo, Makoto;
    • Goto, Koichi;
    • Hirashima, Tomonori;
    • Minato, Koichi;
    • Yada, Nobumichi
    Publication type:
    Article
    8
    9

    dose-finding randomized Phase II study of oral netupitant in combination with palonosetron.75 mg intravenous for the prevention of chemotherapy-induced nausea and vomiting in Japanese patients receiving highly emetogenic chemotherapy.

    Published in:
    Japanese Journal of Clinical Oncology, 2019, v. 49, n. 2, p. 121, doi. 10.1093/jjco/hyy161
    By:
    • Osaki, Akihiko;
    • Inoue, Kenichi;
    • Sakai, Hiroshi;
    • Yamada, Kazuhiko;
    • Minato, Koichi;
    • Ohyanagi, Fumiyoshi;
    • Tokuda, Yutaka;
    • Ikeda, Norihiko;
    • Kagamu, Hiroshi;
    • Kubota, Kaoru;
    • Tamura, Tomohide;
    • Saeki, Toshiaki
    Publication type:
    Article
    10

    Comparative analysis of different response criteria at early phase after PD-1 blockade in non-small lung cancer.

    Published in:
    Cancer Imaging, 2023, v. 23, n. 1, p. 1, doi. 10.1186/s40644-023-00538-x
    By:
    • Kaira, Kyoichi;
    • Yamaguchi, Ou;
    • Naruse, Ichiro;
    • Umeda, Yukihiro;
    • Honda, Takeshi;
    • Watanabe, Satoshi;
    • Ichikawa, Kosuke;
    • Yanagisawa, Shin;
    • Kasahara, Norimitsu;
    • Higuchi, Tetsuya;
    • Hashimoto, Kosuke;
    • Miura, Yu;
    • Shiono, Ayako;
    • Mouri, Atsuto;
    • Imai, Hisao;
    • Iizuka, Kunihiko;
    • Ishizuka, Tamotsu;
    • Minato, Koichi;
    • Suda, Satoshi;
    • Kagamu, Hiroshi
    Publication type:
    Article
    11

    Feasibility study of docetaxel plus bevacizumab as first line therapy for elderly patients with advanced non-small-cell lung cancer: Thoracic Oncology Research Group (TORG) 1014.

    Published in:
    2015
    By:
    • Takagi, Yusuke;
    • Hosomi, Yukio;
    • Oshita, Fumihiro;
    • Okamoto, Hiroaki;
    • Seki, Nobuhiko;
    • Minato, Koichi;
    • Aono, Hiromi;
    • Yamada, Kouzo;
    • Okuma, Yusuke;
    • Hida, Naoya;
    • Sakamoto, Takahiko;
    • Miura, Yosuke;
    • Yomota, Makiko;
    • Satoh, Akira;
    • Kunitoh, Hideo;
    • Sakamaki, Kentaro;
    • Shibuya, Masahiko;
    • Watanabe, Koshiro
    Publication type:
    journal article
    12

    Efficacy and safety of first-line pembrolizumab monotherapy in elderly patients (aged ≥ 75 years) with non-small cell lung cancer.

    Published in:
    Journal of Cancer Research & Clinical Oncology, 2020, v. 146, n. 2, p. 457, doi. 10.1007/s00432-019-03072-1
    By:
    • Imai, Hisao;
    • Wasamoto, Satoshi;
    • Yamaguchi, Ou;
    • Suzuki, Kensuke;
    • Sugiyama, Tomohide;
    • Uchino, Junji;
    • Minemura, Hiroyuki;
    • Osaki, Takashi;
    • Ishii, Hisashi;
    • Umeda, Yukihiro;
    • Mori, Keita;
    • Kotake, Mie;
    • Kagamu, Hiroshi;
    • Morozumi, Nobutoshi;
    • Taniguchi, Hirokazu;
    • Kasai, Takashi;
    • Minato, Koichi;
    • Kaira, Kyoichi
    Publication type:
    Article
    13
    14
    15

    Post-Progression Survival Influences Overall Survival among Patients with Advanced Non-Small Cell Lung Cancer Undergoing First-Line Pembrolizumab Monotherapy.

    Published in:
    Oncology, 2021, v. 99, n. 9, p. 562, doi. 10.1159/000516745
    By:
    • Imai, Hisao;
    • Kishikawa, Takayuki;
    • Minemura, Hiroyuki;
    • Yamada, Yutaka;
    • Ibe, Tatsuya;
    • Mori, Keita;
    • Yamaguchi, Ou;
    • Mouri, Atsuto;
    • Hamamoto, Yoichiro;
    • Kanazawa, Kenya;
    • Kasai, Takashi;
    • Kaira, Kyoichi;
    • Kaburagi, Takayuki;
    • Minato, Koichi;
    • Kobayashi, Kunihiko;
    • Kagamu, Hiroshi
    Publication type:
    Article
    16
    17

    Characteristics and outcomes of patients with EGFR-mutation positive non-small-cell lung cancer receiving gefitinib beyond radiological progression.

    Published in:
    Expert Opinion on Pharmacotherapy, 2018, v. 19, n. 10, p. 1049, doi. 10.1080/14656566.2018.1484903
    By:
    • Hosomi, Yukio;
    • Tanai, Chiharu;
    • Yoh, Kiyotaka;
    • Goto, Yasushi;
    • Sakai, Hiroshi;
    • Kato, Terufumi;
    • Kaburagi, Takayuki;
    • Nishio, Makoto;
    • Kim, Young Hak;
    • Inoue, Akira;
    • Hasegawa, Yoshinori;
    • Isobe, Hiroshi;
    • Tomizawa, Yoshio;
    • Mori, Yoshiaki;
    • Minato, Koichi;
    • Yamada, Kazuhiko;
    • Ohashi, Yasuo;
    • Kunitoh, Hideo
    Publication type:
    Article
    18

    Efficacy and safety of nivolumab in Japanese patients with advanced or recurrent squamous non-small cell lung cancer.

    Published in:
    Cancer Science, 2017, v. 108, n. 5, p. 1000, doi. 10.1111/cas.13225
    By:
    • Hida, Toyoaki;
    • Nishio, Makoto;
    • Nogami, Naoyuki;
    • Ohe, Yuichiro;
    • Nokihara, Hiroshi;
    • Sakai, Hiroshi;
    • Satouchi, Miyako;
    • Nakagawa, Kazuhiko;
    • Takenoyama, Mitsuhiro;
    • Isobe, Hiroshi;
    • Fujita, Shiro;
    • Tanaka, Hiroshi;
    • Minato, Koichi;
    • Takahashi, Toshiaki;
    • Maemondo, Makoto;
    • Takeda, Koji;
    • Saka, Hideo;
    • Goto, Koichi;
    • Atagi, Shinji;
    • Hirashima, Tomonori
    Publication type:
    Article
    19
    20
    21
    22
    23

    Evaluation of gefitinib efficacy according to body mass index, body surface area, and body weight in patients with EGFR-mutated advanced non-small cell lung cancer.

    Published in:
    2017
    By:
    • Imai, Hisao;
    • Kuwako, Tomohito;
    • Kaira, Kyoichi;
    • Masuda, Tomomi;
    • Miura, Yosuke;
    • Seki, Kaori;
    • Sakurai, Reiko;
    • Utsugi, Mitsuyoshi;
    • Shimizu, Kimihiro;
    • Sunaga, Noriaki;
    • Tomizawa, Yoshio;
    • Ishihara, Shinichi;
    • Ishizuka, Takao;
    • Mogi, Akira;
    • Hisada, Takeshi;
    • Minato, Koichi;
    • Takise, Atsushi;
    • Saito, Ryusei;
    • Yamada, Masanobu
    Publication type:
    journal article
    24
    25
    26
    27

    Pretreatment glasgow prognostic score predicts survival among patients administered first-line atezolizumab plus carboplatin and etoposide for small cell lung cancer.

    Published in:
    Frontiers in Oncology, 2023, v. 13, p. 1, doi. 10.3389/fonc.2022.1080729
    By:
    • Satoshi Wasamoto;
    • Hisao Imai;
    • Takeshi Tsuda;
    • Yoshiaki Nagai;
    • Hiroyuki Minemura;
    • Yutaka Yamada;
    • Yukihiro Umeda;
    • Takayuki Kishikawa;
    • Ayako Shiono;
    • Yuki Kozu;
    • Jun Shiihara;
    • Ou Yamaguchi;
    • Atsuto Mouri;
    • Kyoichi Kaira;
    • Kenya Kanazawa;
    • Hirokazu Taniguchi;
    • Takayuki Kaburagi;
    • Koichi Minato;
    • Hiroshi Kagamu
    Publication type:
    Article
    28

    Single-arm multicenter phase II study on aggressive local consolidative therapy in combination with systemic chemotherapy for stage IV non-small cell lung carcinoma with oligometastases: CURE-OLIGO (TORG1529).

    Published in:
    Radiation Oncology, 2025, v. 20, n. 1, p. 1, doi. 10.1186/s13014-024-02577-5
    By:
    • Tokito, Takaaki;
    • Yamada, Kazuhiko;
    • Ishii, Hidenobu;
    • Takiguchi, Yuichi;
    • Saito, Go;
    • Minato, Koichi;
    • Imai, Hisao;
    • Tanaka, Hiroshi;
    • Miura, Satoru;
    • Watanabe, Kageaki;
    • Koreeda, Yoshifusa;
    • Ono, Akira;
    • Furuya, Naoki;
    • Misumi, Toshihiro;
    • Hayakawa, Kazushige;
    • Ogo, Etsuyo;
    • Okamoto, Hiroaki
    Publication type:
    Article
    29

    Clinical Significance of Various Drug-Sensitivity Markers in Patients with Surgically Resected Pulmonary Pleomorphic Carcinoma.

    Published in:
    Cancers, 2019, v. 11, n. 11, p. 1636, doi. 10.3390/cancers11111636
    By:
    • Imai, Hisao;
    • Shimizu, Kimihiro;
    • Kawashima, Osamu;
    • Endoh, Hideki;
    • Imaizumi, Kazuyoshi;
    • Goto, Yasuhiro;
    • Kamiyoshihara, Mitsuhiro;
    • Sugano, Masayuki;
    • Yamamoto, Ryohei;
    • Tanaka, Shigebumi;
    • Fujita, Atsushi;
    • Kogure, Yoshihito;
    • Seki, Yukio;
    • Mogi, Akira;
    • Oyama, Tetsunari;
    • Minato, Koichi;
    • Asao, Takayuki;
    • Kaira, Kyoichi
    Publication type:
    Article
    30
    31
    32
    33

    First-line nivolumab plus ipilimumab combined with two cycles of chemotherapy in advanced non-small cell lung cancer: a subanalysis of Asian patients in CheckMate 9LA.

    Published in:
    International Journal of Clinical Oncology, 2022, v. 27, n. 4, p. 695, doi. 10.1007/s10147-022-02120-0
    By:
    • John, Thomas;
    • Sakai, Hiroshi;
    • Ikeda, Satoshi;
    • Cheng, Ying;
    • Kasahara, Kazuo;
    • Sato, Yuki;
    • Nakahara, Yoshiro;
    • Takeda, Masayuki;
    • Kaneda, Hiroyasu;
    • Zhang, Helong;
    • Maemondo, Makoto;
    • Minato, Koichi;
    • Hisada, Takeshi;
    • Misumi, Yuki;
    • Satouchi, Miyako;
    • Hotta, Katsuyuki;
    • Li, Ang;
    • Oukessou, Abderrahim;
    • Lu, Shun
    Publication type:
    Article
    34
    35

    A double-blind randomized phase II dose-finding study of olanzapine 10 mg or 5 mg for the prophylaxis of emesis induced by highly emetogenic cisplatin-based chemotherapy.

    Published in:
    International Journal of Clinical Oncology, 2018, v. 23, n. 2, p. 382, doi. 10.1007/s10147-017-1200-4
    By:
    • Yanai, Takako;
    • Iwasa, Satoru;
    • Hashimoto, Hironobu;
    • Ohyanagi, Fumiyoshi;
    • Takiguchi, Tomomi;
    • Takeda, Koji;
    • Nakao, Masahiko;
    • Sakai, Hiroshi;
    • Nakayama, Toshiaki;
    • Minato, Koichi;
    • Arai, Takahiro;
    • Suzuki, Kenichi;
    • Shimada, Yasuhiro;
    • Nagashima, Kengo;
    • Terakado, Hiroyuki;
    • Yamamoto, Noboru
    Publication type:
    Article
    36
    37
    38

    Clinical Outcomes of Postoperative Adjuvant Chemotherapy for Surgically Resected High-Grade Pulmonary Neuroendocrine Carcinoma.

    Published in:
    Chemotherapy (0009-3157), 2022, v. 67, n. 3, p. 142, doi. 10.1159/000524077
    By:
    • Kotake, Mie;
    • Imai, Hisao;
    • Kaira, Kyoichi;
    • Endoh, Hideki;
    • Yamada, Yutaka;
    • Kaburagi, Takayuki;
    • Kiyoshima, Moriyuki;
    • Sugiyama, Tomohide;
    • Nakamura, Yoichi;
    • Kasai, Takashi;
    • Matsuguma, Haruhisa;
    • Minemura, Hiroyuki;
    • Kanazawa, Kenya;
    • Suzuki, Hiroyuki;
    • Fujita, Atsushi;
    • Minato, Koichi
    Publication type:
    Article
    39
    40
    41
    42
    43
    44

    Phase II Trial on Osimertinib as a First-Line Treatment for EGFR Mutation-Positive Advanced NSCLC in Elderly Patients: The SPIRAL-0 Study.

    Published in:
    Oncologist, 2022, v. 27, n. 11, p. 903, doi. 10.1093/oncolo/oyac193
    By:
    • Chihara, Yusuke;
    • Takeda, Takayuki;
    • Goto, Yasuhiro;
    • Nakamura, Yoichi;
    • Tsuchiya-Kawano, Yuko;
    • Nakao, Akira;
    • Onoi, Keisuke;
    • Hibino, Makoto;
    • Fukuda, Minoru;
    • Honda, Ryoichi;
    • Yamada, Takahiro;
    • Taniguchi, Ryusuke;
    • Sakamoto, Sinjiro;
    • Date, Koji;
    • Nagashima, Seiji;
    • Tanzawa, Shigeru;
    • Minato, Koichi;
    • Nakatani, Koichi;
    • Izumi, Miiru;
    • Shimose, Takayuki
    Publication type:
    Article
    45

    Low‐Dose Olanzapine Plus Granisetron and Dexamethasone for Carboplatin‐Induced Nausea and Vomiting in Patients with Thoracic Malignancies: A Prospective Multicenter Phase II Trial.

    Published in:
    Oncologist, 2021, v. 26, n. 6, p. e1066, doi. 10.1002/onco.13772
    By:
    • Sakai, Chizuru;
    • Shimokawa, Mototsugu;
    • Iihara, Hirotoshi;
    • Fujita, Yukiyoshi;
    • Ikemura, Shinnosuke;
    • Hirose, Chiemi;
    • Kotake, Mie;
    • Funaguchi, Norihiko;
    • Gomyo, Takenobu;
    • Imai, Hisao;
    • Hakamata, Jun;
    • Kaito, Daizo;
    • Minato, Koichi;
    • Arai, Takahiro;
    • Kawazoe, Hitoshi;
    • Suzuki, Akio;
    • Ohno, Yasushi;
    • Okura, Hiroyuki
    Publication type:
    Article
    46
    47

    Pretreatment Glasgow prognostic score predicts survival among patients with high PD‐L1 expression administered first‐line pembrolizumab monotherapy for non‐small cell lung cancer.

    Published in:
    Cancer Medicine, 2021, v. 10, n. 20, p. 6971, doi. 10.1002/cam4.4220
    By:
    • Imai, Hisao;
    • Kishikawa, Takayuki;
    • Minemura, Hiroyuki;
    • Yamada, Yutaka;
    • Ibe, Tatsuya;
    • Yamaguchi, Ou;
    • Mouri, Atsuto;
    • Hamamoto, Yoichiro;
    • Kanazawa, Kenya;
    • Kasai, Takashi;
    • Kaira, Kyoichi;
    • Kaburagi, Takayuki;
    • Minato, Koichi;
    • Kobayashi, Kunihiko;
    • Kagamu, Hiroshi
    Publication type:
    Article
    48
    49

    Three‐year follow‐up results from phase II studies of nivolumab in Japanese patients with previously treated advanced non‐small cell lung cancer: Pooled analysis of ONO‐4538‐05 and ONO‐4538‐06 studies.

    Published in:
    Cancer Medicine, 2019, v. 8, n. 11, p. 5183, doi. 10.1002/cam4.2411
    By:
    • Horinouchi, Hidehito;
    • Nishio, Makoto;
    • Hida, Toyoaki;
    • Nakagawa, Kazuhiko;
    • Sakai, Hiroshi;
    • Nogami, Naoyuki;
    • Atagi, Shinji;
    • Takahashi, Toshiaki;
    • Saka, Hideo;
    • Takenoyama, Mitsuhiro;
    • Katakami, Nobuyuki;
    • Tanaka, Hiroshi;
    • Takeda, Koji;
    • Satouchi, Miyako;
    • Isobe, Hiroshi;
    • Maemondo, Makoto;
    • Goto, Koichi;
    • Hirashima, Tomonori;
    • Minato, Koichi;
    • Sumiyoshi, Naoki
    Publication type:
    Article
    50

    Phase I/II study of induction chemotherapy using carboplatin plus irinotecan and sequential thoracic radiotherapy (TRT) for elderly patients with limited-disease small-cell lung cancer (LD-SCLC): TORG 0604.

    Published in:
    2017
    By:
    • Yuki Misumi;
    • Hiroaki Okamoto;
    • Jiichiro Sasaki;
    • Noriyuki Masuda;
    • Mari Ishii;
    • Tsuneo Shimokawa;
    • Yukio Hosomi;
    • Yusuke Okuma;
    • Makoto Nagamata;
    • Takashi Ogura;
    • Terufumi Kato;
    • Masafumi Sata;
    • Sakiko Otani;
    • Akira Takakura;
    • Koichi Minato;
    • Yosuke Miura;
    • Takuma Yokoyama;
    • Saori Takata;
    • Katsuhiko Naoki;
    • Koshiro Watanabe
    Publication type:
    journal article